Hoyoung Huh
Founder & CEO
Description:
Hoyoung Huh, MD/Ph.D., is a Silicon Valley-based entrepreneur and investor who is inspired by innovative science, collaborative creativity, and impact investing. Hoyoung is a global leader in healthcare and technology-based businesses, having founded or grown more than 20 innovative companies. He founded Hannol Ventures, pH Pharma, and the Healthcare and Humanity Foundation. He is currently the Chairman/CEO of pH Pharma, as well as the Chairman of Geron Corporation (NASDAQ: GERN), CytomX Therapeutics (NASDAQ:CTMX), and AntriaBio (OTC:ANTB), and Shared-X in Peru. Dr. Huh holds a B.S. in biochemistry from Dartmouth College, an M.D. from Cornell University Medical College, and a Ph.D. in genetics/cell biology from Cornell University/Sloan-Kettering Institute.
Summary:
Hoyoung Huh, MD/Ph.D., is a Silicon Valley-based entrepreneur and investor who is inspired by innovative science, collaborative creativity, ...
Number of Registered Investments:2
Contact Details:
- Address: United States, North America
- No email is provided
Location:United States, North America
Email is Not Provided
Phone Number:United States, North America
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.